Municipal Employees Retirement System of Michigan decreased its position in LivaNova PLC (NASDAQ:LIVN) by 17.7% during the second quarter, Holdings Channel reports. The institutional investor owned 16,510 shares of the company’s stock after selling 3,540 shares during the period. Municipal Employees Retirement System of Michigan’s holdings in LivaNova PLC were worth $1,011,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of the company. Meadow Creek Investment Management LLC boosted its stake in LivaNova PLC by 11.4% in the first quarter. Meadow Creek Investment Management LLC now owns 2,464 shares of the company’s stock worth $121,000 after buying an additional 252 shares in the last quarter. Glen Harbor Capital Management LLC boosted its stake in LivaNova PLC by 11.4% in the first quarter. Glen Harbor Capital Management LLC now owns 2,992 shares of the company’s stock valued at $147,000 after buying an additional 306 shares during the period. Exane Derivatives boosted its stake in LivaNova PLC by 814.8% in the second quarter. Exane Derivatives now owns 3,156 shares of the company’s stock valued at $158,000 after buying an additional 2,811 shares during the period. LS Investment Advisors LLC boosted its stake in LivaNova PLC by 14.5% in the second quarter. LS Investment Advisors LLC now owns 3,449 shares of the company’s stock valued at $211,000 after buying an additional 436 shares during the period. Finally, Capstone Asset Management Co. acquired a new stake in LivaNova PLC during the first quarter valued at approximately $233,000. Hedge funds and other institutional investors own 73.41% of the company’s stock.
Shares of LivaNova PLC (NASDAQ LIVN) opened at 61.78 on Friday. LivaNova PLC has a 12-month low of $40.83 and a 12-month high of $64.95. The firm has a 50-day moving average price of $61.64 and a 200 day moving average price of $55.08. The stock has a market cap of $3.02 billion, a PE ratio of 110.32 and a beta of 0.62.
LivaNova PLC (NASDAQ:LIVN) last posted its quarterly earnings results on Wednesday, August 9th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.19. The firm had revenue of $321.40 million for the quarter, compared to analyst estimates of $315.75 million. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The firm’s revenue was up .1% compared to the same quarter last year. Equities research analysts predict that LivaNova PLC will post $3.16 EPS for the current fiscal year.
Separately, BidaskClub cut LivaNova PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th.
In related news, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction on Monday, July 17th. The stock was sold at an average price of $61.55, for a total transaction of $61,550.00. Following the transaction, the director now directly owns 56,437 shares of the company’s stock, valued at $3,473,697.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have sold 3,000 shares of company stock worth $180,840 over the last three months. 0.28% of the stock is owned by insiders.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.